HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

4-cymene (p-cymene)

structure
Also Known As:
p-cymene; p-cymol; p-cimene; p-isopropyltoluene
Networked: 110 relevant articles (7 outcomes, 17 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Sadler, Peter J: 10 articles (01/2021 - 01/2010)
2. Dyson, Paul J: 8 articles (10/2018 - 09/2008)
3. Keppler, Bernhard K: 6 articles (10/2018 - 05/2009)
4. Paira, Priyankar: 5 articles (05/2022 - 09/2020)
5. Hartinger, Christian G: 5 articles (01/2021 - 09/2008)
6. Romero-Canelón, Isolda: 5 articles (10/2019 - 02/2013)
7. Arion, Vladimir B: 5 articles (07/2013 - 05/2009)
8. Jakupec, Michael A: 5 articles (07/2013 - 05/2009)
9. Roy, Nilmadhab: 4 articles (05/2022 - 12/2020)
10. Mukherjee, Arindam: 4 articles (04/2021 - 01/2010)

Related Diseases

1. Neoplasms (Cancer)
2. Lung Neoplasms (Lung Cancer)
3. Acute Lung Injury
4. Ovarian Neoplasms (Ovarian Cancer)
10/16/2019 - "Here, we study time-dependent accumulation of FY26 in A2780 human ovarian cancer cells at various temperatures in comparison with the chlorido metabolite [(η6-p-cymene)Os(Ph-azopyridine-NMe2)Cl]+ (FY25). "
02/21/2017 - "Here, it was found that the sub-cellular distribution of [Os(η6 -p-cym)(Azpy-NMe2 )I]+ (p-cym=p-cymene, Azpy-NMe2 =2-(p-[dimethylamino]phenylazo)pyridine) (1), a promising drug candidate, can be mapped in human ovarian cancer cells at pharmacological concentrations using a synchrotron X-ray fluorescence nanoprobe (SXRFN). "
01/01/2016 - "These activities are improved when compared to the already known corresponding curcumin complex, (p-cymene)Ru(curcuminato)Cl, about twice for the breast and ovarian cancer, 4.7 times stronger in the lung cancer and about 6.6 times stronger in the glioblastoma cell lines. "
11/25/2010 - "Iodido osmium(II) complexes [Os(η(6)-arene)(XY)I](+) (XY = p-hydroxy or p-dimethylaminophenylazopyridine, arene = p-cymene or biphenyl) are potently cytotoxic at nanomolar concentrations toward a panel of human cancer cell lines; e.g., IC(50) = 140 nM for [Os(η(6)-bip)(azpy-NMe(2))I](+) toward A2780 ovarian cancer cells. "
01/01/2022 - "In this study, we present the synthesis, kinetic studies of inhibitory activity toward aldo-keto reductase 1C (AKR1C) enzymes, and anticancer potential toward chemoresistant ovarian cancer of 10 organoruthenium compounds bearing diketonate (1-6) and hydroxyquinolinate (7-10) chelating ligands with the general formula [(η6-p-cymene)Ru(chel)(X)]n+ where chel represents the chelating ligand and X the chlorido or pta ligand. "
5. Breast Neoplasms (Breast Cancer)

Related Drugs and Biologics

1. Volatile Oils (Essential Oils)
2. Monoterpenes (Monoterpenoids)
3. Thymol
4. Acetates (Acetic Acid Esters)
5. linalyl acetate
6. octanoic acid (caprylic acid)
7. Cisplatin (Platino)
8. dichloro(4- cymene)(1,3,5- triaza- 7- phosphatricyclo(3.3.1.1)decane)ruthenium(II)
9. DNA (Deoxyribonucleic Acid)
10. Organometallic Compounds

Related Therapies and Procedures

1. Precision Medicine
2. Combination Drug Therapy (Combination Chemotherapy)
3. Therapeutics
4. Immunomodulation
5. Synchrotrons